http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0301133-A3

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5084
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
filingDate 1987-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1990-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0301133-A3
titleOfInvention Long acting formulation
abstract A long acting sustained release pharmaceutical ncomposition for dihydropyridine calcium channel blockers nwherein the calcium channel blocker and a pH-dependent nbinder are intimately admixed in essentially spherically nshaped non-rugose particles of up to 1.2 mm in diameter.
priorityDate 1987-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0205336-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0204596-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0231026-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0142561-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226424268
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66586608
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226424269
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66586609

Total number of triples: 23.